ArticleBritish journal of cancer2025
Novel Skp1 inhibitor has potent preclinical efficacy against castration-resistant prostate cancer.
Xin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it